Table 2.
Selected clinical characteristics and associations with all-cause mortality among women diagnosed with ovarian cancer (N = 703).
| Characteristic | No. of deaths/total (%) |
Crude HR (95% CI) |
Adjusted HRa (95% CI) |
|---|---|---|---|
| Age at diagnosis | |||
| ≤ 50 | 45/258 (17.44) | 1.00 (ref) | 1.00 (ref) |
| >50 | 85/445 (19.10) | 1.18 (0.82–1.70) | 1.24 (0.85–1.79) |
| Histological type | |||
| Serous | 92/479 (19.21) | 1.00 (ref) | 1.00 (ref) |
| Non-serous | 38/224 (16.96) | 0.87 (0.59–1.27) | 1.71 (1.11–2.66) |
| Histopathologic grade | |||
| Well-differentiated | 5/56 (8.93) | 1.00 (ref) | 1.00 (ref) |
| Moderately differentiated | 7/48 (14.58) | 1.44 (0.46–4.57) | 1.12 (0.35–3.57) |
| Poorly differentiated | 118/599 (19.70) | 2.32 (0.95–5.67) | 1.76 (0.70–4.43) |
| FIGO stage | |||
| I–II | 41/342 (11.99) | 1.00 (ref) | 1.00 (ref) |
| III–IV | 89/338 (26.33) | 2.75 (1.89–4.00) | 2.54 (1.65–3.91) |
| Residual lesions | |||
| No | 82/553 (14.83) | 1.00 (ref) | 1.00 (ref) |
| <1 cm | 31/106 (29.25) | 2.22 (1.47–3.36) | 1.73 (1.11–2.68) |
| ≥1 cm | 17/44 (38.64) | 3.18 (1.89–5.37) | 2.41 (1.39–4.16) |
| Comorbidities | |||
| No | 74/393 (18.83) | 1.00 (ref) | 1.00 (ref) |
| Yes | 56/310 (18.06) | 0.82 (0.58–1.16) | 0.97 (0.68–1.38) |
a
Mutually adjusted for all other variables listed in the table.
CI, confidence interval; HR, hazard ratio; Ref, reference.